Evidence map›Paper›PMID 20887897›Full record

ArticleCell2010

Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5.

Rushad Pavri, Anna Gazumyan, Mila Jankovic, Michela Di Virgilio, Isaac Klein, Camilo Ansarah-Sobrinho, Wolfgang Resch, Arito Yamane, Bernardo Reina San-Martin, Vasco Barreto and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 243 papers.

0numbers the graph read from it
0cells of the map it votes in
243citing papers in PubMed
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

243 citing papers in PubMed, 366 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

183 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Rushad PavriLaboratory of Molecular Immunology, The Rockefeller University, New York, New York 10065, USA.
Anna Gazumyan
Mila Jankovic
Michela Di Virgilio
Isaac Klein
Camilo Ansarah-Sobrinho
Wolfgang Resch
Arito Yamane
Bernardo Reina San-Martin
Vasco Barreto
Thomas J Nieland
David E Root
Rafael Casellas
Michel C Nussenzweig
Rockefeller University · USNational Institutes of Health · USBroad Institute · USInstituto Gulbenkian de Ciência · PT

Funding

Class Switch Recombination in B LymphocytesR37AI037526 · NIAID · ROCKEFELLER UNIVERSITY · PI NUSSENZWEIG, MICHEL C · 2014 to 2023
$5.4M
SIGNALLING PATHWAYS IN AUTOIMMUNITYR01AI037526 · NIAID · ROCKEFELLER UNIVERSITY · PI NUSSENZWEIG, MICHEL C · 1994 to 2012
$5.0M
Howard Hughes Medical InstituteNIAID NIH HHS AI037526NIAID NIH HHS R01 AI037526NIAID NIH HHS R37 AI037526
6 · The paper itself

Abstract

Activation-induced cytidine deaminase (AID) initiates antibody gene diversification by creating U:G mismatches. However, AID is not specific for antibody genes; Off-target lesions can activate oncogenes or cause chromosome translocations. Despite its importance in these transactions little is known about how AID finds its targets. We performed an shRNA screen to identify factors required for class switch recombination (CSR) of antibody loci. We found that Spt5, a factor associated with stalled RNA polymerase II (Pol II) and single stranded DNA (ssDNA), is required for CSR. Spt5 interacts with AID, it facilitates association between AID and Pol II, and AID recruitment to its Ig and non-Ig targets. ChIP-seq experiments reveal that Spt5 colocalizes with AID and stalled Pol II. Further, Spt5 accumulation at sites of Pol II stalling is predictive of AID-induced mutation. We propose that AID is targeted to sites of Pol II stalling in part via its association with Spt5.

Indexed as

Immunoglobulin Class SwitchingAICDA (Activation-Induced Cytidine Deaminase)AnimalsB-LymphocytesCell LineCell Line, TumorChromosomal Proteins, Non-HistoneCytidine DeaminaseFibroblastsHumansImmunoglobulinsMiceRNA Polymerase IITranscriptional Elongation FactorsAICDA (Activation-Induced Cytidine Deaminase)Chromosomal Proteins, Non-HistoneCytidine DeaminaseImmunoglobulinsRNA Polymerase IISPT5 transcriptional elongation factorTranscriptional Elongation Factors

Identifiers

PMID20887897
PMCPMC2993080
OpenAlexW2017629702

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.